Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rifkin

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 10, 2013
TNF inhibition for ophthalmic indications: current status and outlookLana M Rifkin, Andrea D Birnbaum, Debra A Goldstein
Behring Institute Mitteilungen|August 1, 1988
A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusionR M Rifkin, E M Hersh, S E Salmon
Future Oncology (London, England)|January 24, 2022
Analytical similarity as base for rituximab biosimilars in lymphoid malignancies in the clinic: a PF-05280586 case studyJeff P Sharman, Carol F Kirchhoff, Robert M Rifkin
The Lancet. Oncology|November 8, 2016
Safety and efficacy of biosimilars in oncologyHuub Schellekens, Josef S Smolen, Mario Dicato, et al.
Heart and Vessels|January 1, 1988
Assessment of lung water by magnetic resonance in three types of pulmonary edemaS Vinitski, R M Steiner, H R Wexler, et al.
Ocular Immunology and Inflammation|October 25, 2014
A new OCT finding in tuberculous serpiginous-like choroidopathyLana M Rifkin, Marion R Munk, Dina Baddar, et al.
Cancer|January 13, 2006
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trialRobert M Rifkin, Stephanie A Gregory, Ann Mohrbacher, et al.
Cancer Investigation|June 17, 1999
Growth of oncology physician practice management companiesK Mighion, D H Gesme, R M Rifkin, et al.
Retinal Cases & Brief Reports|July 30, 2016
TARANTULA HAIR ASSOCIATED PANUVEITIS TREATED WITH SUSTAINED-RELEASE INTRAVITREAL DEXAMETHASONE IMPLANTMelina I Morkin, Lana M Rifkin, Sabin Dang, et al.
Metabolism: Clinical and Experimental|October 1, 1980
The relationship between somatostatin binding and cyclic AMP-stimulated protein kinase inhibitionJ W Leitner, R M Rifkin, A Maman, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 10, 2013
TNF inhibition for ophthalmic indications: current status and outlookLana M Rifkin, Andrea D Birnbaum, Debra A Goldstein
Behring Institute Mitteilungen|August 1, 1988
A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusionR M Rifkin, E M Hersh, S E Salmon
Future Oncology (London, England)|January 24, 2022
Analytical similarity as base for rituximab biosimilars in lymphoid malignancies in the clinic: a PF-05280586 case studyJeff P Sharman, Carol F Kirchhoff, Robert M Rifkin
The Lancet. Oncology|November 8, 2016
Safety and efficacy of biosimilars in oncologyHuub Schellekens, Josef S Smolen, Mario Dicato, et al.
Heart and Vessels|January 1, 1988
Assessment of lung water by magnetic resonance in three types of pulmonary edemaS Vinitski, R M Steiner, H R Wexler, et al.
Ocular Immunology and Inflammation|October 25, 2014
A new OCT finding in tuberculous serpiginous-like choroidopathyLana M Rifkin, Marion R Munk, Dina Baddar, et al.
Cancer|January 13, 2006
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trialRobert M Rifkin, Stephanie A Gregory, Ann Mohrbacher, et al.
Cancer Investigation|June 17, 1999
Growth of oncology physician practice management companiesK Mighion, D H Gesme, R M Rifkin, et al.
Retinal Cases & Brief Reports|July 30, 2016
TARANTULA HAIR ASSOCIATED PANUVEITIS TREATED WITH SUSTAINED-RELEASE INTRAVITREAL DEXAMETHASONE IMPLANTMelina I Morkin, Lana M Rifkin, Sabin Dang, et al.
Metabolism: Clinical and Experimental|October 1, 1980
The relationship between somatostatin binding and cyclic AMP-stimulated protein kinase inhibitionJ W Leitner, R M Rifkin, A Maman, et al.
Pageof 9